Such-Lupe

Notices in accordance with WpHG and WpPG

Ad hoc releases 2010

09/28/2010
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA: Burdening special effects in the amount of approx. EUR 29.5 million before taxes as a result of liquidity problems of Serbian wholesalers
More information (PDF)
 
07/26/2010
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA: Dr. Axel Müller will be the new Chief Production and Development Officer – Christof Schumann resigns from Executive Board responsibilities
More information (PDF)
 
06/07/2010
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA's targets for 2014: EBITDA ca. EUR 430 mio with sales of ca. EUR 2.15 bn – “STADA – build the future” aiming to sustainably increase earnings introduced – total burdening one-time special effects of ca. EUR 50 mio, of which ca. EUR 10 mio in 2010
More information (PDF)
 
05/10/2010
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA: Appointment of Executive Board member Christof Schumann not extended
More information (PDF)
 
03/01/2010
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA: Net profit significantly improved – dividend set for further increase based on good preliminary results for 2009 – Positive outlook for 2010
More information (PDF)
 
The current STADA share price with share price chart including Excel download and market capitalization of STADA Arzneimittel AG are available here. We also offer you an interactive peer group share price comparison. More
Here you can read an online version of the last 4 financial reports on your screen, download the PDF or order a hard copy. Older financial reports are available in PDF format from our archive. More
Don’t miss any publication or event! Have a look at our overview of all important financial events of STADA Arzneimittel AG for the current year and the next. More

 

(c) 2013 STADA Arzneimittel AG, Stadastraße 2-18, 61118 Bad Vilbel, Telefon 06101 603-0, Fax 06101 603-259, e-Mail: info@stada.de